Home › Funds › Genus Capital Management Inc. › JNJ

Genus Capital Management Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Genus Capital Management Inc. reported holding 39,907 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$10.6M, representing 1.05% of its reported portfolio and ranking #26 among its reported holdings. Genus Capital Management Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)39.91K sh
Reported value held$10.56M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Genus Capital Management Inc.'s JNJ position evolved

Genus Capital Management Inc. first disclosed a stake in JNJ in Q3 2023 at 7,780 shares (US$1.2M). The position peaked in Q1 2026 at 55,935 shares, worth US$13.7M. Across 13 filings, Genus Capital Management Inc. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 39,907 shares valued at US$10.6M — a reduction of -8,946 shares quarter over quarter.. Notable position changes include a 76% trim in Q4 2023 (shares rose 1% over the following quarter), a 686% increase in Q3 2025 (shares rose 11% over the following quarter), a 399% increase in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.78K $1.21M New
Q4 2023 1.89K $296.24K Reduce
Q1 2024 1.83K $289.49K Reduce
Q2 2024 1.55K $226.55K Reduce
Q3 2024 1.55K $251.19K Hold
Q4 2024 1.55K $224.16K Hold
Q1 2025 1.47K $243.78K Reduce
Q2 2025 1.39K $212.32K Reduce
Q3 2025 10.93K $2.03M Add
Q4 2025 54.55K $11.29M Add
Q1 2026 55.94K $13.67M Add
Q2 2026 48.85K $12.41M Reduce
Q3 2026 39.91K $10.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Genus Capital Management Inc. held JNJ?

Genus Capital Management Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Genus Capital Management Inc.'s current position in JNJ?

As of Q3 2026, Genus Capital Management Inc. holds 39.91K shares of JNJ (JOHNSON & JOHNSON), valued at $10.56M, representing 1.05% of its reported portfolio and ranking #26.

Has Genus Capital Management Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Genus Capital Management Inc. reduced its position in JNJ. The position peaked in Q1 2026 at 55.94K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.